Medication info

Genasid Dry Syrup 800 mg/5 mL (Acyclovir)

Prescription medicationExpired
Ingredient · strength
Acyclovir›Strength being verified
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Light pink powder for reconstitution
Packaging
20 grams (suspension of 30 mL), 320 grams (suspension of 480 mL)
Approval status
Expired

MFDS item code 199801313 · Notified 1998.12.22

This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of chickenpox; treatment and prevention of herpes simplex (including genital herpes); treatment of shingles
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is preferable to administer as soon as possible after infection; in recurrent cases, administer at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically discontinued every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is preferable to administer as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more susceptible to neuropsychiatric adverse reactions; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of chickenpox; treatment and prevention of herpes simplex (including genital herpes); treatment of shingles

  • Primary genital herpes
  • recurrent genital herpes
  • skin herpes simplex virus infections
  • mucosal tissue herpes simplex virus infections
  • herpes zoster virus infections
  • acute herpes zoster pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections of the skin and mucosal tissues, including primary and recurrent genital herpes. It is also very effective for the treatment of herpes zoster virus infections and helps alleviate pain associated with the acute phase. However, the effect on postherpetic neuralgia has not yet been clearly demonstrated. Additionally, it is used for the treatment of chickenpox in children over 2 years old. Therefore, this medicine is effective for various herpes virus infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is preferable to administer as soon as possible after infection; in recurrent cases, administer at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically discontinued every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is preferable to administer as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more susceptible to neuropsychiatric adverse reactions; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Precautions

This medicine should not be used in patients who have had an allergic reaction to this drug or any of its components, including valacyclovir. Patients with poor renal function may be prone to neurological adverse reactions while taking this medicine, so caution is advised. Patients with impaired liver function may be at risk of further worsening liver function when taking this medicine, so it should be used cautiously. Infants and children should use this medicine with greater caution, and it should only be given in the minimum effective dose when necessary. Elderly patients may have diminished kidney function, leading to prolonged drug retention in the body, increasing the risk of adverse reactions, so dosage and administration intervals should be adjusted, and adequate hydration is necessary. During this treatment, rare occurrences of anaphylactic shock or severe allergic reactions can arise; thus, if symptoms such as low blood pressure, difficulty breathing, or chest tightness occur, the medication should be discontinued immediately and medical attention sought. Skin rash, fever, blisters, hives may occur, and severe skin conditions such as Stevens-Johnson syndrome or Lyell syndrome may present as symptoms. Neuropsychiatric symptoms like confusion, drowsiness, tremors, seizures, hallucinations, anxiety, insomnia, etc., can occur, particularly more frequently in elderly patients or those with renal impairment. Deteriorating kidney function can lead to renal failure, hematuria, and proteinuria, so caution is needed. Hematological abnormalities such as leukopenia, anemia, bleeding, and purpura may appear, so consult a doctor immediately if symptoms occur. Liver function may worsen, leading to hepatitis and jaundice symptoms; inform your doctor if there are existing liver health issues. Gastrointestinal symptoms like nausea, vomiting, abdominal pain, and diarrhea may appear; if these symptoms are severe, discontinue use and consult a doctor. This medicine should be changed to another treatment if symptoms do not improve or worsen, especially for the treatment of herpes simplex, chickenpox, and herpes zoster, the early administration of which is most effective. Patients with compromised immune functions may need to consider intravenous alternatives instead of this medicine. Adequate hydration is required during this treatment to prevent dehydration and reduce the risk of renal toxicity. In the treatment of recurrent genital herpes, the need to continue treatment should be reviewed after one year of administration. This medication may cause consciousness disturbances, so caution should be taken when driving or operating dangerous machinery, and those with renal impairment should be particularly careful. There may be interactions if this medicine is taken with others, so inform your doctor or pharmacist if you are taking probenecid, cimetidine, theophylline, or mycophenolate mofetil. Pregnant women or those who could become pregnant should carefully consider the necessity and risks of treatment with this medicine as it may affect the fetus. Components of this medication can be transmitted through breast milk, so it is advisable to discontinue breastfeeding during treatment. Infants and children should use this medicine minimally, particularly in neonates or low birth weight infants, where safety has not been established and should be administered cautiously. Elderly patients should adjust dosage and administration intervals due to prolonged drug retention related to decreased renal function, and should drink plenty of water. Overdosage may lead to agitation, stupor, seizures, and renal failure, in which case serum drug levels should be measured and treatment such as dialysis may be required as necessary. There have been reports of mutagenicity with high doses of this medicine; however, it is known that routine recommended doses do not affect sperm count.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 118 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration disturbances
  • aggressive behavior
  • depersonalization
  • anxiety
  • akinesia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • verbal hallucinations
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • anorexia
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • hypoproteinemia
  • increased total cholesterol levels
  • increased triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it should be stored in a tightly closed container. When storing, avoid direct sunlight and keep it at room temperature.

Appearance and packaging

Appearance

Light pink powder for reconstitution

Package unit

20 grams (suspension of 30 mL), 320 grams (suspension of 480 mL)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.